Navigation Links
MO BIO Laboratories, Inc. Launches the RTS DNase™ Kit
Date:9/21/2011

CARLSBAD, Calif., Sept. 21, 2011 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of the RTS DNase™ Kit, which includes the first room temperature stable DNase I enzyme.

(Photo: http://photos.prnewswire.com/prnh/20110921/LA65994)

The RTS DNase™ Kit efficiently removes contaminating genomic DNA from RNA preparations while protecting valuable RNA samples from damage during the DNase treatment process. RTS DNase is the first DNase I enzyme which is stable at room temperature, eliminating concern about freeze-thaw cycles that may decrease enzymatic activity. The RTS DNase™ Kit also contains a novel and highly specific resin which is used to bind and remove the RTS DNase enzyme and divalent cations from the reaction for optimal QPCR results. Protection of RNA is ensured, as the kit contains only Certified RNase-free reagents and does not require heat, EDTA or harsh chemicals.  

The RTS DNase™ Kit is available now. For more information, visit the MO BIO website (http://www.mobio.com/dnase/rts-dnase-kit.html) or call 800-606-6246 to order.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in Molecular Biology since 1993. A global leader in solutions for soil and microbial nucleic acid purification, MO BIO's Power® kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For samples that do not require inhibitor removal, MO BIO's UltraClean® line includes optimized products for DNA and RNA isolation from a variety of sample types. For clinical samples, the BiOstic™ kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
2. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
3. MO BIO Laboratories, Inc. Launches Dye Dots™ Dry Gel Loading Dye
4. MO BIO Laboratories, Inc. DNA Isolation Products Used to Analyze Microbes Present in Deepwater Horizon Oil Plume
5. MO BIO Laboratories, Inc. Launches PowerLyzer(TM) 24 Bench Top Bead-Based Homogenizer
6. MO BIO Laboratories, Inc. Launches PowerBiofilm(TM) DNA and RNA Isolation Kits
7. MO BIO Laboratories, Inc. Launches PowerWater(R) RNA Isolation Kit
8. DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
9. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
10. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
11. Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing and commercializing products to treat rare diseases ... today the long-term follow-up data from its Phase ... Innate Defense Regulator (IDR), in the treatment of ... patients undergoing chemoradiation therapy (CRT).  The additional 12-month ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/8/2016)... 2016 Eutilex Co. Ltd. today announced that ... Series A financing. This financing round included participation from ... SNU Bio Angel. This new funding brings the total ... $27.7M) since its founding in 2015. ... and commercialization of its immuno-oncology programs, expand its R&D ...
(Date:12/8/2016)... , Dec. 8, 2016   Biocept, Inc ... commercial provider of clinically actionable liquid biopsy tests ... that clinical data featuring its Target Selector™ Circulating ... biopsy for the detection of actionable biomarkers in ... research sponsored by Sara Cannon Research Institute (SCRI), ...
Breaking Biology Technology:
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Valencell , the leading innovator in ... a third consecutive year of triple digit growth for ... with a 360 percent increase in companies who have ... driven by sales of its wrist and ear Benchmark™ ... technology for hearables for fitness and healthcare applications. ...
(Date:11/30/2016)... FRANCISCO and WARSAW, Poland , Nov. 30, 2016 /PRNewswire/ ... It is one of the most crucial aspects of recovery so we need to ... of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and even ... and friends sleep and find a Christmas present that could help them to manage ... ...
Breaking Biology News(10 mins):